Literature DB >> 31664538

Correlation analysis of hepatitis C virus core antigen and low viral loads: Can core antigen replace nucleic acid test?

Bo Feng1, Rui-Feng Yang2, Han-Ji Jiang2, Yan-Di Xie2, Hai-Ying Zhang2, Qian Jin2, Xu Cong2, Lai Wei3.   

Abstract

Value of hepatitis C virus (HCV) core antigen (cAg) test has been controversy in patients with low HCV loads for its lower sensitivity. We assessed correlation between HCV-cAg and HCV RNA in serum samples with low viral loads and analyzed the performance of HCV-cAg assay in determining diagnosis and treatment outcomes in chronic hepatitis C patients. Both HCV RNA and HCV-cAg were detected for 2298 serum samples. Correlation analysis was performed between the two tests. Receiver operating characteristics (ROC) curve was used to assess value of HCV-cAg test in determining diagnosis and response outcomes at the different HCV RNA thresholds. The two tests were correlated very well, and moreover, correlation in the low viral load group was higher than that in the high viral load group (r value: 0.901 and 0.517). Positive agreement of HCV-cAg ≥ 3 fmol/L was as high as 97.0% for HCV RNA ≥ 1000 IU/mL, and its negative agreement for HCV RNA < 15 IU/mL was up to 98.9% in all samples. Area under ROCs ranged from 0.939 to 0.992, regardless of HCV RNA thresholds. When lower limit of detection of HCV RNA was 15, 100 or 1000 IU/mL, positive predictive value of HCV-cAg was 96.8%, 98.8% or 92.4%, and its negative predictive value was 87.0%, 89.9% or 98.3%, respectively, on the basis of different cutoff values. High-sensitivity HCV-cAg detection may likely replace HCV RNA to confirm the existence of HCV and to guide the treatment of chronic HCV infection.

Entities:  

Keywords:  Diagnosis; HCV RNA; HCV core antigen; Hepatitis C; Treatment

Mesh:

Substances:

Year:  2019        PMID: 31664538     DOI: 10.1007/s10238-019-00588-1

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  3 in total

1.  Resistant-Associated Substitutions Do Not Affect HCV RNA and HCV Core Antigen Clearance During Direct-Acting Antiviral Agent Treatment in a Real-World Setting.

Authors:  Hongyu Chen; Jianxiang Liu; Qian Kang; Hao Luo; Ning Tan; Jiali Pan; Yuqing Yang; Min Yu; Dan Liu; Hongli Xi; Yifan Han; Ran Cheng; Yanyan Yu; Xiaoyuan Xu
Journal:  Infect Drug Resist       Date:  2022-06-28       Impact factor: 4.177

2.  Performance of HCV Antigen Testing for the Diagnosis and Monitoring of Antiviral Treatment: A Systematic Review and Meta-Analysis.

Authors:  Geane Lopes Flores; Jurema Corrêa Mota; Larissa Tropiano da Silva Andrade; Renata Serrano Lopes; Francisco Inácio Bastos; Livia Melo Villar
Journal:  Biomed Res Int       Date:  2022-01-04       Impact factor: 3.411

3.  Laboratory-based dried blood spot testing for hepatitis C: A protocol for systematic review and meta-analysis of diagnostic accuracy.

Authors:  Paul G Carty; Michael McCarthy; Sinead O'Neill; Patricia Harrington; Michelle O'Neill; Conor Teljeur; Susan M Smith; Máirín Ryan
Journal:  HRB Open Res       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.